TW455590B - Monophosphate salt of isopropyl-methyl-[2-(3-n-propoxyphenoxy)ethyl]amine, pharmaceutical composition and preparation process thereof - Google Patents

Monophosphate salt of isopropyl-methyl-[2-(3-n-propoxyphenoxy)ethyl]amine, pharmaceutical composition and preparation process thereof Download PDF

Info

Publication number
TW455590B
TW455590B TW087120433A TW87120433A TW455590B TW 455590 B TW455590 B TW 455590B TW 087120433 A TW087120433 A TW 087120433A TW 87120433 A TW87120433 A TW 87120433A TW 455590 B TW455590 B TW 455590B
Authority
TW
Taiwan
Prior art keywords
item
scope
ethyl
phosphoric acid
patent application
Prior art date
Application number
TW087120433A
Other languages
English (en)
Inventor
Karol Horvath
Ulf Larsson
Rune Sandberg
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Application granted granted Critical
Publication of TW455590B publication Critical patent/TW455590B/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/06Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
    • C07C217/14Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring
    • C07C217/18Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
    • C07C217/20Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted by halogen atoms, by trihalomethyl, nitro or nitroso groups, or by singly-bound oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics
    • A61P23/02Local anaesthetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Anesthesiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Claims (1)

  1. 公告 案號 455590 87120433_々£?年公丨嚼'應 申請專利範圍 丨補尤 y 十 ΪΜ 1 一種異丙基甲基-[2-(3_正-丙氧基苯氧基)乙基]胺 之單碟酸鹽。 一種製備異丙基-甲基-[2-(3 -正-丙氧基苯氧基)乙 g之單磷酸鹽之方法,其包括以下步驟: i)添加磷酸至異丙基-曱基-[2-(3 -正-丙氧基苯氧基) 乙基]胺之有機溶劑系統溶液内; i i )使該溶液結晶化; 丙氧基 步驟i ) 步驟i ) 該醇系 步驟i ) 步驟i ) 完全添 〇 添加 間。 異丙基- iii)離析因此獲得之異丙基-曱基-[2-(3 -正-苯氧基)乙基]胺之單磷酸鹽。 3. 根據令請專利範圍第2項之方法,其特徵在於 中所使用之有機溶劑系統為醋酸乙酯。 4. 根據申請專利範圍第2項之方法,其特徵在於 中所添加之磷酸係以磷酸之醇系、容液型式添加。 溶液 6. 中使用0.9-1.0當量之磷酸。 7.根據申請專利範圍第2項之方法,其特徵在於 中使用0.95當量之鱗酸。 8 .根據申請專利範圍第2項之方法,其特徵在於 加後,所形成溶液中之磷酸濃度在5 - 1 0重量%之間 9.根據申請專利範圍第2項之方法,其特徵在於 後,所形成溶液中之磷酸濃度應該在9 - 1 1重量%之 1 0 · —種用於治療疼痛之醫藥組合物,其含有該 5. 根據申請專利範圍第4項之方法,其特徵在於 是曱醇系溶液。 根據申請專利範圍第2項之方法,其特徵在於
    O:\55\55855.ptc 第1頁 2001. 07. 12. 009
    O:\55\55855.ptc 第2頁 2001.07. 12.010 公告 案號 455590 87120433_々£?年公丨嚼'應 申請專利範圍 丨補尤 y 十 ΪΜ 1 一種異丙基甲基-[2-(3_正-丙氧基苯氧基)乙基]胺 之單碟酸鹽。 一種製備異丙基-甲基-[2-(3 -正-丙氧基苯氧基)乙 g之單磷酸鹽之方法,其包括以下步驟: i)添加磷酸至異丙基-曱基-[2-(3 -正-丙氧基苯氧基) 乙基]胺之有機溶劑系統溶液内; i i )使該溶液結晶化; 丙氧基 步驟i ) 步驟i ) 該醇系 步驟i ) 步驟i ) 完全添 〇 添加 間。 異丙基- iii)離析因此獲得之異丙基-曱基-[2-(3 -正-苯氧基)乙基]胺之單磷酸鹽。 3. 根據令請專利範圍第2項之方法,其特徵在於 中所使用之有機溶劑系統為醋酸乙酯。 4. 根據申請專利範圍第2項之方法,其特徵在於 中所添加之磷酸係以磷酸之醇系、容液型式添加。 溶液 6. 中使用0.9-1.0當量之磷酸。 7.根據申請專利範圍第2項之方法,其特徵在於 中使用0.95當量之鱗酸。 8 .根據申請專利範圍第2項之方法,其特徵在於 加後,所形成溶液中之磷酸濃度在5 - 1 0重量%之間 9.根據申請專利範圍第2項之方法,其特徵在於 後,所形成溶液中之磷酸濃度應該在9 - 1 1重量%之 1 0 · —種用於治療疼痛之醫藥組合物,其含有該 5. 根據申請專利範圍第4項之方法,其特徵在於 是曱醇系溶液。 根據申請專利範圍第2項之方法,其特徵在於
    O:\55\55855.ptc 第1頁 2001. 07. 12. 009
TW087120433A 1997-12-22 1998-12-09 Monophosphate salt of isopropyl-methyl-[2-(3-n-propoxyphenoxy)ethyl]amine, pharmaceutical composition and preparation process thereof TW455590B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9704835A SE9704835D0 (sv) 1997-12-22 1997-12-22 New compound

Publications (1)

Publication Number Publication Date
TW455590B true TW455590B (en) 2001-09-21

Family

ID=20409538

Family Applications (1)

Application Number Title Priority Date Filing Date
TW087120433A TW455590B (en) 1997-12-22 1998-12-09 Monophosphate salt of isopropyl-methyl-[2-(3-n-propoxyphenoxy)ethyl]amine, pharmaceutical composition and preparation process thereof

Country Status (22)

Country Link
US (1) US6235792B1 (zh)
EP (1) EP1047663A1 (zh)
JP (1) JP2001526254A (zh)
KR (1) KR20010033407A (zh)
CN (1) CN1280559A (zh)
AR (1) AR017199A1 (zh)
AU (1) AU1989299A (zh)
BR (1) BR9814381A (zh)
CA (1) CA2314989A1 (zh)
EE (1) EE200000384A (zh)
HU (1) HUP0004428A3 (zh)
ID (1) ID26940A (zh)
IL (1) IL136829A0 (zh)
IS (1) IS5544A (zh)
NO (1) NO20003216L (zh)
PL (1) PL341525A1 (zh)
SE (1) SE9704835D0 (zh)
SK (1) SK8062000A3 (zh)
TR (1) TR200002012T2 (zh)
TW (1) TW455590B (zh)
WO (1) WO1999032431A1 (zh)
ZA (1) ZA9811237B (zh)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH380746A (de) 1958-11-06 1964-08-15 Ciba Geigy Verfahren zur Herstellung neuer sekundärer Amine
AR004691A1 (es) 1995-10-27 1999-03-10 Astrazeneca Ab Nuevos derivados de [3-alcoxi-fenoxi-)-etil]-dialquilamina, una composicion farmaceutica que los comprende, su uso como anestesicos locales y unprocedimiento para su preparacion

Also Published As

Publication number Publication date
PL341525A1 (en) 2001-04-23
US6235792B1 (en) 2001-05-22
IL136829A0 (en) 2001-06-14
SK8062000A3 (en) 2001-02-12
CA2314989A1 (en) 1999-07-01
CN1280559A (zh) 2001-01-17
SE9704835D0 (sv) 1997-12-22
WO1999032431A1 (en) 1999-07-01
ZA9811237B (en) 1999-07-19
HUP0004428A2 (hu) 2002-03-28
BR9814381A (pt) 2000-10-10
AR017199A1 (es) 2001-08-22
EE200000384A (et) 2001-12-17
ID26940A (id) 2001-02-22
HUP0004428A3 (en) 2002-04-29
AU1989299A (en) 1999-07-12
IS5544A (is) 2000-06-21
EP1047663A1 (en) 2000-11-02
KR20010033407A (ko) 2001-04-25
NO20003216D0 (no) 2000-06-21
TR200002012T2 (tr) 2000-10-23
JP2001526254A (ja) 2001-12-18
NO20003216L (no) 2000-06-21

Similar Documents

Publication Publication Date Title
JP3808499B2 (ja) 安定化オルトケイ酸含有調製物および生物学的調製物
US7893110B2 (en) Carboxylic acid amides provoking a cooling sensation
CH616080A5 (zh)
CA1229093A (en) Process for preparing quaternary ammonium salts
US20080112899A1 (en) Carboxamides and Their Use
JPH01165524A (ja) 局所適用のための医薬又は化粧品組成物
JP2010526827A5 (zh)
BG62066B2 (bg) (s)-(-)-1-пропил-2',6'-пипеколоксилидидов хидрохлорид монохидрат, метод за получаването му и фармацевтичен препарат, който го съдържа
JPS5984822A (ja) 獣医用鎮痛剤
JPH0322993A (ja) 水溶性l−チロシン誘導体およびl−チロシン誘導体の製造方法
JPH07509458A (ja) 抗過血糖症および/または抗肥満活性を有するホスホン化アリールエタノールアミン化合物
TW455590B (en) Monophosphate salt of isopropyl-methyl-[2-(3-n-propoxyphenoxy)ethyl]amine, pharmaceutical composition and preparation process thereof
US4017628A (en) Treatment of mange
US2212831A (en) Manufacture of stable derivative of adrenaline
JP3200723B2 (ja) 育毛剤
JPH0376306B2 (zh)
JP2005508350A5 (zh)
ES2220138T3 (es) Composiciones solubles de toremifeno.
JP3893002B2 (ja) 入浴剤
JP2020515621A5 (zh)
JP2006515314A (ja) チオクト酸のl−カルニチンとの塩基性塩
Hartung et al. A NEW SERIES OF ANESTHETICS. ACYLANILINE DERIVATIVES
US3068146A (en) Combatting pathogenic organisms by means of n-hydroxymethylamino compounds
CA1125773A (fr) SEL DE LYSINE DE L'ACIDE (.SUP. .SUB.-) AMINO-3 (PYRROLYL)-1')-4-.alpha.-METHYL PHENYL ACETIQUE, PROCEDE DE PREPARATION ET MEDICAMENT LE CONTENANT
KR101061618B1 (ko) 아미드 유도체 화합물 및 이의 제조 방법과 이를 포함하는 유화제 및 모발 컨디셔닝 조성물

Legal Events

Date Code Title Description
GD4A Issue of patent certificate for granted invention patent
MM4A Annulment or lapse of patent due to non-payment of fees